Inventor · disambiguated record
Garth A. Kinberger
Also filed as: KINBERGER GARTH A
11 granted patents·15 pending applications·170 citations·filing 2005–2024
91Inventor score
Files withIONIS PHARMACEUTICALS INC8ISIS PHARMACEUTICALS INC5ASTRAZENECA AB4ATALANTA THERAPEUTICS INC2ESAU CHRISTINE2
Top patents by PatentIndex Score
26 records- 0197US7713944B2Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cellsISIS PHARMACEUTICALS INC·Filed 2005·Granted May 11, 2010·42 cites·18 claims
- 0295US8129515B2Oligomeric compounds and compositions for the use in modulation of microRNAsESAU CHRISTINE·Filed 2007·Granted Mar 6, 2012·60 cites·27 claims
- 0394US9738895B2Oligomeric compounds and methodsIONIS PHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·10 cites·21 claims
- 0494US8987435B2Oligomeric compounds and methodsSWAYZE ERIC E·Filed 2009·Granted Mar 24, 2015·20 cites·23 claims
- 0593US9127272B2Oligomeric compounds and compositions for the use in modulation of target nucleic acidsESAU CHRISTINE·Filed 2012·Granted Sep 8, 2015·17 cites·9 claims
- 0690US11104899B2Oligomer-conjugate complexes and their useIONIS PHARMACEUTICALS INC·Filed 2018·Granted Aug 31, 2021·3 cites·20 claims
- 0788US10098959B2Method for synthesis of reactive conjugate clustersIONIS PHARMACEUTICALS INC·Filed 2015·Granted Oct 16, 2018·5 cites·18 claims
- 0888US9598693B2Oligomeric compounds and compositions for the use in modulation of micrornasIONIS PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·3 cites·15 claims
- 0987US10023861B2Oligomer-conjugate complexes and their usePRAKASH THAZHA P·Filed 2012·Granted Jul 17, 2018·9 cites·21 claims
- 1082US12115225B2GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2021·Granted Oct 15, 2024·1 cites·12 claims
- 1172US2024293563A1Glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1271US2022025370A1Oligomer-conjugate complexes and their useIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1366US2025188471A1Noncovalently branched oligonucleotide compositionsATALANTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1466US2020270609A1Single-Stranded RNAI Oligonucleotides Targeting APOC-IIIIONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1566US2024294913A1Methods and Compositions for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1662US2011046206A1Double strand compositions comprising differentially modified strands for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1761US2024287526A1Compositions and methods for delivering therapeutic oligonucleotides to the central nervous systemATALANTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1858US10751419B2Method for synthesis of reactive conjugate clustersIONIS PHARMACEUTICALS INC·Filed 2018·Granted Aug 25, 2020·0 cites·20 claims
- 1958US2016122761A1Compositions and methods for modulation of target nucleic acidsISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2057US2019127737A1Single-stranded rnai oligonucleotides targeting apoc-iiiIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2154US2013035369A1Double strand compositions comprising differentially modified strands for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2253US2025136979A1Methods and Compositions for Avoiding Off-Target EffectsREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2352US2020268898A1Glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 2448US2009306178A1Conjugated double strand compositions for use in gene modulationBHAT BALKRISHEN·Filed 2007·Application pending·0 cites
- 2547US2015315579A1Double strand compositions comprising differentially modified strands for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2641US2019134214A1GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses ThereofASTRAZENECA AB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Garth A. Kinberger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →